Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort. [electronic resource] by
- Jelinek, Tomas
- Popkova, Tereza
- Duras, Juraj
- Mihalyova, Jana
- Kascak, Michal
- Benkova, Katerina
- Plonkova, Hana
- Cerna, Lucie
- Koristek, Zdenek
- Simicek, Michal
- Hajek, Roman
Producer: 20201015
In:
Hematological oncology vol. 38
Availability: No items available.
|
|
9.
|
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14). [electronic resource] by
- Jelinek, Tomas
- Mihalyova, Jana
- Kascak, Michal
- Duras, Juraj
- Popkova, Tereza
- Benkova, Katerina
- Richterova, Petra
- Plonkova, Hana
- Zuchnicka, Jana
- Broskevicova, Lucie
- Huvarova, Lucie
- Cerna, Lucie
- Growkova, Katerina
- Simicek, Michal
- Havel, Martin
- Gumulec, Jaromir
- Navratil, Milan
- Koristek, Zdenek
- Paiva, Bruno
- Hajek, Roman
Producer: 20191112
In:
American journal of hematology vol. 94
Availability: No items available.
|